Coloplast A/S (OTCMKTS:CLPBY) Shares Unloaded Rep. Josh Gottheimer

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Coloplast A/S (OTCMKTS:CLPBY). In a filing disclosed on January 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Coloplast A/S stock on December 27th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.

Representative Josh Gottheimer also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Block (NYSE:SQ) on 12/30/2024.
• Purchased $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 12/30/2024.
• Sold $1,001 – $15,000 in shares of Ambev (NYSE:ABEV) on 12/27/2024.
• Sold $1,001 – $15,000 in shares of Grupo Financiero Banorte (OTCMKTS:GBOOY) on 12/27/2024.
• Sold $1,001 – $15,000 in shares of Cadre (NYSE:CDRE) on 12/27/2024.
• Sold $1,001 – $15,000 in shares of Intuitive Surgical (NASDAQ:ISRG) on 12/23/2024.
• Sold $1,001 – $15,000 in shares of Trane Technologies (NYSE:TT) on 12/23/2024.
• Purchased $1,001 – $15,000 in shares of Walmart (NYSE:WMT) on 12/20/2024.
• Sold $1,001 – $15,000 in shares of NVIDIA (NASDAQ:NVDA) on 12/19/2024.
• Purchased $1,001 – $15,000 in shares of Walmart (NYSE:WMT) on 12/19/2024.

Coloplast A/S Trading Up 0.5 %

CLPBY stock opened at $10.98 on Thursday. The company has a current ratio of 1.02, a quick ratio of 0.66 and a debt-to-equity ratio of 0.92. The firm has a 50-day moving average of $11.86 and a two-hundred day moving average of $12.68. Coloplast A/S has a 12 month low of $10.63 and a 12 month high of $14.34.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.08 EPS for the quarter. The firm had revenue of $1.02 billion during the quarter. Coloplast A/S had a return on equity of 30.19% and a net margin of 18.69%. As a group, equities research analysts expect that Coloplast A/S will post 0.36 EPS for the current fiscal year.

Coloplast A/S Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Monday, December 9th were given a dividend of $0.2435 per share. The ex-dividend date of this dividend was Monday, December 9th. This is a positive change from Coloplast A/S’s previous dividend of $0.05. Coloplast A/S’s payout ratio is presently 93.94%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CLPBY. Hsbc Global Res raised shares of Coloplast A/S from a “moderate sell” rating to a “hold” rating in a research note on Monday, November 18th. UBS Group upgraded Coloplast A/S from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 11th.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2025. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2024 election. Gottheimer was first elected to the House in 2016. Prior to his election, Gottheimer worked for Microsoft, the Federal Communications Commission, and for the administration of President Bill Clinton (D). Click here for more information about Gottheimer’s career. Gottheimer serves on the House Financial Services Committee, where is a member of three subcommittees. For more on Gottheimer’s committee assignments, click here. Gottheimer became a co-chair of the Problem Solvers Caucus in February 2017. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.